The establishment of method for examining bacterial endotoxin in foscarnet sodium with LAL; 目的进行第七批细菌内毒素国家标准品原料制备方法的研究。
Objective To investigate the effectiveness of foscarnet sodium in the treatment of patients with chronic severe hepatitis B. 目的:探讨膦甲酸钠治疗慢性重型乙型肝炎的疗效。
The therapeutic efficacy of foscarnet sodium in the treatment of patients with chronic hepatitis B of severe type 膦甲酸钠治疗慢性乙型肝炎重度患者的临床观察
Objective To investigate the clinical effect and safety of foscarnet sodium in herpes zoster. 目的:观察膦甲酸钠治疗带状疱疹的临床疗效及安全性。
Experimental Study on Value of Foscarnet Sodium in Acute Liver Injury Model of Rats Induced by BCG and LPS 膦甲酸钠对免疫致敏大鼠急性肝损伤模型的干预作用研究
The clinical efficacy of combination therapy of foscarnet sodium and interferon in treatment of chronic hepatitis B 膦甲酸钠联合干扰素治疗慢性乙型病毒性肝炎的临床疗效
Preliminary study of the efficacy of foscarnet sodium in treatment of patients with cytomegalovirus infection after renal transplantation 膦甲酸钠在肾移植术后临床应用的初步研究
Jaundice ( 3) D shape. ( 2) C shape; Effects of foscarnet sodium on severe icteric hepatitis B 膦甲酸钠治疗重度黄疸型乙型肝炎的研究
Clinical observation of treatment of gravis hepatitis B with foscavir see foscarnet sodium and thymic peptide-α_1 膦甲酸钠联合胸腺肽-α1治疗重型肝炎的临床观察
Foscarnet sodium in treatment of 38 patients with severe hepatitis B 膦甲酸钠治疗乙型重型肝炎38例
Study on the Compatible Stability of Foscarnet Sodium Injection with 4 Infusion Solutions 膦甲酸钠注射液与4种大输液的配伍稳定性考察
Conclusion Foscarnet sodium injection has a good effect on severe chronic hepatitis B patients and it is safe to use on them. 结论膦甲酸钠注射液治疗重度慢性乙型病毒性肝炎有较好的疗效和安全性。
Conclusion Foscarnet sodium can safely and effectively treat patients with severe hepatitis B and decrease the fatality of severe hepatitis B. 结论膦甲酸钠可以安全有效地治疗乙型重型肝炎,明显降低病死率。
Objective: Both efficiency and safety about 3% foscarnet sodium and 0 1% acyclovir eye drops on treatment of 164 cases of herpes simplex keratitis were observed and compared. 目的:观察和比较3%膦甲酸钠和01%无环鸟苷滴眼液治疗单纯疱疹性角膜炎的疗效和安全性。
OBJECTIVE: To observe the efficacy and safety of foscarnet sodium in treatment of patients with cytomegalovirus ( CMV) after renal transplantation. 目的:研究膦甲酸钠(foscarnetsodium,PFA)预防及治疗肾移植术后巨细胞病毒(cytomegalovirus,CMV)感染的临床疗效。
Potent anti-HBV treatment with nucleoside analogues and foscarnet sodium injection effectively improved patient clinical condition. 强有力的抗乙肝病毒治疗重新实施,核苷酸类似物结合膦甲酸钠注射液有效地改善了患者的临床状况。
Aims: To explore the value of Foscarnet sodium in acute liver injury model of rats induced by BCG. 目的:探讨膦甲酸钠对免疫诱导的大鼠急性肝损伤的干预作用。